Published in Cancer on February 01, 2007
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. Cancer Prev Res (Phila) (2010) 1.91
Immunohistochemistry in the evaluation of neovascularization in tumor xenografts. Biotech Histochem (2008) 1.27
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia (2012) 0.89
Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation. Carcinogenesis (2012) 0.81
Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo. Int J Mol Sci (2010) 0.80
Effects of cyclooxygenase inhibitors on survival time in ovarian cancer xenograft-bearing mice. Oncol Lett (2012) 0.77
Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy. Biol Res (2014) 0.76
An observational study on the expression of cyclooxygenase-2 in meningioma. Adv Biomed Res (2014) 0.75
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet (2006) 9.56
Impact of fellowship training on research productivity in academic neurological surgery. World Neurosurg (2013) 3.36
The prevalence of pituitary adenomas: a systematic review. Cancer (2004) 2.98
Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science (2007) 2.25
Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg (2005) 2.19
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol (2002) 2.16
The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2011) 2.15
Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res (2002) 2.10
Coincident pituitary adenoma and sellar meningioma. Acta Neurochir (Wien) (2014) 2.01
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature. Spine (Phila Pa 1976) (2003) 1.86
Pituitary carcinoma: a review of the literature. Neurosurg Focus (2004) 1.77
Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem (2005) 1.73
Ruptured intracranial dermoid cysts: clinical, radiographic, and surgical features. Neurosurgery (2008) 1.69
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med (2002) 1.66
Primary Intraosseous Skull Base Cavernous Hemangioma: Case Report. Skull Base (2003) 1.63
Metastases to the pituitary gland. Neurosurg Focus (2004) 1.63
Use of the h index in neurosurgery. Clinical article. J Neurosurg (2009) 1.60
Career satisfaction and burnout among U.S. neurosurgeons: a feasibility and pilot study. World Neurosurg (2012) 1.58
Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J Exp Med (2003) 1.58
Transcortical-transforaminal microscopic approach for purely intraventricular craniopharyngioma. Neurosurg Focus (2013) 1.58
De novo fenestration of the optic nerve. Case illustration. J Neurosurg (2005) 1.58
Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg (2004) 1.55
The combined transmastoid retro- and infralabyrinthine transjugular transcondylar transtubercular high cervical approach for resection of glomus jugulare tumors. Neurosurgery (2006) 1.52
Traumatic pseudoaneurysms of the head and neck: early endovascular intervention. J Vasc Surg (2007) 1.52
Transnasal excerebration surgery in ancient Egypt. J Neurosurg (2012) 1.48
Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol (2002) 1.43
The frontotemporal (pterional) approach: an historical perspective. Neurosurgery (2012) 1.41
The management of trauma venous injury: civilian and wartime experiences. Perspect Vasc Surg Endovasc Ther (2006) 1.40
Upper extremity arterial combat injury management. Perspect Vasc Surg Endovasc Ther (2006) 1.39
Patton: death of a soldier. Historical vignette. J Neurosurg (2008) 1.39
Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci (2003) 1.39
Tunneled lumbar drain. Technical note. J Neurosurg (2002) 1.39
Venous trauma: new lessons and old debates. Perspect Vasc Surg Endovasc Ther (2011) 1.38
Aneurysms of the petrous internal carotid artery: anatomy, origins, and treatment. Neurosurg Focus (2004) 1.36
Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation (2005) 1.33
Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res (2007) 1.31
The role of cyclooxygenase-2 and prostaglandins in colon cancer. Prostaglandins Other Lipid Mediat (2006) 1.29
Contemporary management of wartime vascular trauma. J Vasc Surg (2005) 1.29
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Neurosurg Focus (2010) 1.27
Diacylglycerol kinases. Cell Signal (2004) 1.25
The emerging roles of PAF acetylhydrolase. J Lipid Res (2008) 1.22
Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery (2006) 1.22
Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. Proc Natl Acad Sci U S A (2005) 1.21
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol (2010) 1.21
Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling. Proc Natl Acad Sci U S A (2006) 1.20
Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol (2003) 1.19
Neurosurgical workforce trends in the United States. J Neurosurg (2005) 1.18
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer (2008) 1.18
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest (2006) 1.18
Call to action to prevent venous thromboembolism. J Vasc Surg (2009) 1.17
Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus (2004) 1.16
Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol (2005) 1.15
Fenestration of the oculomotor nerve by a duplicated posterior cerebral artery and aneurysm. Case report. J Neurosurg (2009) 1.15
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res (2006) 1.13
Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer (2007) 1.13
Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg (2009) 1.12
Association of diacylglycerol kinase zeta with protein kinase C alpha: spatial regulation of diacylglycerol signaling. J Cell Biol (2003) 1.11
Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol (2006) 1.09
Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock (2006) 1.09
Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem Biophys Res Commun (2002) 1.08
Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol (2006) 1.08
Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg (2012) 1.07
Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg (2007) 1.06
Inflammatory pseudotumor of the cavernous sinus and skull base. Neurosurg Rev (2006) 1.05
Photophobia in a blind patient: An alternate visual pathway. Case report. J Neurosurg (2006) 1.05
Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery (2005) 1.04
Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev (2007) 1.04
Hemorrhagic and nonhemorrhagic Rathke cleft cysts mimicking pituitary apoplexy. J Neurosurg (2008) 1.04
WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol (2008) 1.03
Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol (2006) 1.03
Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg (2003) 1.03
Surgical treatment of craniofacial fibrous dysplasia in adults. Neurosurg Rev (2013) 1.02
IFN-epsilon mediates TNF-alpha-induced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells. J Immunol (2007) 1.01
Molecular genetics of meningiomas. Neurosurg Focus (2005) 1.00
Subependymomas: an analysis of clinical and imaging features. Neurosurgery (2006) 1.00
Protein kinase C alpha phosphorylates and negatively regulates diacylglycerol kinase zeta. J Biol Chem (2003) 1.00
Diacylglycerol kinase zeta regulates phosphatidylinositol 4-phosphate 5-kinase Ialpha by a novel mechanism. Cell Signal (2004) 1.00
Surgical considerations regarding giant dilations of the perivascular spaces. J Neurosurg (2004) 1.00
The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J Biol Chem (2006) 0.99
Synaptic removal of diacylglycerol by DGKzeta and PSD-95 regulates dendritic spine maintenance. EMBO J (2009) 0.98
Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus (2004) 0.98
Porous polyethylene implant for cranioplasty and skull base reconstruction. Neurosurg Focus (2004) 0.98
Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery ® and the American Venous Forum. J Vasc Surg (2014) 0.98
Communication between malignant glioma cells and vascular endothelial cells through gap junctions. J Neurosurg (2003) 0.97
Embolic atrial myxoma causing aortic and carotid occlusion. Surg Neurol (2008) 0.97
Surgical approaches for resection of vestibular schwannomas: translabyrinthine, retrosigmoid, and middle fossa approaches. Neurosurg Focus (2012) 0.97
Fish oil fix. Nat Med (2005) 0.97
Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression. Cancer Lett (2008) 0.97
Harvey Cushing and Oskar Hirsch: early forefathers of modern transsphenoidal surgery. J Neurosurg (2005) 0.97
Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clin Oncol (2005) 0.96
Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg (2004) 0.95
Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg (2007) 0.95
Surgical decision-making strategies in tuberculum sellae meningioma resection. Neurosurg Focus (2011) 0.94